health – Forte Medical

Forte Medical case study within Imperial College Innovation paper

30th July2023/in AMR, analysis, British business, business, diagnosis, diligence, Disruption, Enterprise, Evidence, export, FemTech, Finance, health, healthcare, infection control, innovation, Investment, Investors, medicine, MedTech, midstream, patient safety, pregnancy, research, sample, SME, specimen, testing, Uncategorized, urine, UTI /by Giovanna

Commissioned by Lord Sainsbury and authored by Professor James Moore and Yunus Kutlu, Imperial College has published a report on innovation adoption in the UK and wh

at prevents successful adoption of impactful innovation. Forte Medical features as the only case study and outlines issues with silo systems, a disconnect between procurement and fincance all topped off with vested interests from labs and leadership.

The Peezy Midstream case study outlines how adoption of preventative devices and practice are resisted, leading to missed opportunities for improved patient health, prompt diagnoses, prevention and huge cost savings across the patient pathway.

Read all about it here. – see Page 29 and Appendix 2

Imperial Business School: a MedTech to Market Journey

15th November2022/in AMR, analysis, antenatal, British business, business, diagnosis, Enterprise, Evidence, export, FemTech, Finance, health, healthcare, infection control, innovation, Investment, Investors, medicine, MedTech, midstream, patient safety, pregnancy, pregnant, research, sample, screening, Series A, SME, specimen, Uncategorized, urine, USA, UTI /by Giovanna

Giovanna’s annual talk to the Imperial Business School took place last week; here we share the presentation Deck. Had she known in 2002 what she knows now, it would have taken a third of the time to create three specimen collection products and a springboard to global reach. She and Dr Vincent Forte are beyond proud of what they have achieved. 202210_ForteMedical_HealthTech_Commercialisation_Journey

Antibiotics and urinary tract infections

Antibiotics, better tests, UTI: Guardian publishes Forte response

8th October2019/in AMR, analysis, antenatal, clinic, diagnosis, diligence, Disruption, health, healthcare, hospital, hygiene, infection control, innovation, medicine, MedTech, midstream, patient safety, pregnancy, pregnant, research, sample, screening, specimen, testing, Uncategorised, urine, UTI /by Forte Medical

A rise in persistent UTIs could be linked to antibiotic crackdown appeared in The Guardian on Saturday 5th October. As usual, no-one mentioned accurate basic specimen collection, which can lead to unwarranted specimen quality variation, failed analysis and less-than-targeted prescribing. Giovanna Forte had something to say. Click here to read her published letter.

A Year In Review – 2018

18th December2018/in antenatal, business, diagnosis, Enterprise, export, health, Investment, MedTech, midstream, research /by Forte Medical

New evidence showing a 70% reduction in false positive dipped specimens
Extended uptake by the NHS
Investment including a JV to create a Smart Peezy
Sheena Byrom joining our Advisory Panel
Being recognised in the Sunday Times 2018 Maserati 100 list that celebrate British entrepreneurship

These have been a few of our highlights for 2018 – to read more, please click here

Mr Ased Ali – Making Urine Samples Trustworthy

6th November2018/in analysis, diagnosis, diligence, health, infection control, midstream, patient safety, sample, specimen, testing, urine /by Forte Medical

The latest issue of Urology News features an interesting and important conversation with Urological Consultant Mr Ased Ali about the importance of urine in diagnosis and subsequent treatment of UTIs. He refers to the patient-led initiative – the MUST Campaign – that is demanding Government introduce a protocol for the collection of urine specimens.

The article supports the work being undertaken – the petition can be signed here – and the article itself is on page 35 of the November/December issue.

Clinical research using the Peezy Midstream shows a 70% reduction in false positive dipped urines and mixed growth/contamination reduced from the national average of 22.5% to just 2%. Our contribution to making urine samples trustworthy

Knowledge of Men’s Health Dangerously Low

29th October2018/in diagnosis, health, patient safety, specimen, urine /by Forte Medical

Amongst British adults, urology diseases such as testicular cancer and prostate cancer are not well understood and men are not looking out for the signs and symptoms of these deadly diseases.

This was the revealing and shocking research undertaken as part of Urology Awareness Month that was presented at our Forum last month by The Urology Foundation’s CEO, Louise de Winter.

70% of British adults do not know the correct age from which men should be tested for prostate cancer
2 in 3 British adults do not know what a prostate does
More than half of British adults do not know the age range when men are most likely to get testicular cancer
Half of British men have not checked their testicles for lumps in the last year (doctors recommend once a month)

Read here for more information from The Urology Foundation.

Peezy Midstream Case Study at NHS NIHR Conference 2018

12th October2018/in analysis, business, diagnosis, health, health & safety, healthcare, hospital, hygiene, infection control, midstream, patient safety, research, sample, specimen, testing /by Forte Medical

Back in March of this year, the NHS National Institute for Health Research contacted Forte Medical, asking for a case study demonstrating how their research has assisted the launch of Peezy Midstream.

A few months earlier the NIHR in conjunction with the West Midlands AHSN conducted a valuable Usability Study on our diagnostic device. Results were excellent and have assisted us with adoption training and reassurance to HCPs and patients alike that using Peezy Midstream is far, far easier than trying to deliver this elusive urine specimen any other way …

The case study presented by Giovanna Forte on 10th October 2018 was very well received and has already led to enquiries from Primary Care clinicians who can see the benefit of right-first-time diagnoses for UTI and other common conditions that can take up so much GP time when left untreated.

2018 NIHR Peezy Presentation

NIHR_PeezyMidstream-Case-Study

Forte Medical: Series A investment growth round is open

20th June2018/in British business, business, Disruption, Enterprise, FemTech, Finance, health, healthcare, innovation, Investment, Investors, medicine, Series A, SME, Uncategorised /by Forte Medical

This week saw the launch of Forte Medical’s Series A investment round for growth, export and new product development. Seeking £3.5m, the company is engaging with prospective investment partners who can attract investors with an interest in evidenced, disruptive diagnostic medical devices with digital potential.

Institutional, corporate or personal investors who can assist the business long term are seen as the most promising and attractive partners. For more information, contact our CEO Giovanna Forte.

Disruptive TV: Giant Live Health Innovators

11th June2018/in AMR, analysis, antenatal, business, diagnosis, diligence, health, health & safety, healthcare, hygiene, infection control, innovation, medicine, MedTech, midstream, patient safety, pregnancy, pregnant, sample, screening, specimen, testing, Uncategorised, urine, UTI /by Forte Medical

Barry Shrier, Founder of annual health innovation event Giant Live, presents the third Disruptor Giant Health Innovators TV interview featuring Giovanna Forte, CEO of Forte Medical, Francis White from AliveCor, Dr Sophie Bostock of Sleepio and Etienne Bourdon from Healthy Health. Watch the half-hour programme here with Disruptive Live

Trends in Urology & Men’s Health: solving the problem of contaminated urine samples

7th February2018/in diagnosis, health, innovation, medicine, midstream, specimen, testing, urine, UTI /by Forte Medical

Despite its importance, there is no standard for urine collection. In this article the author, Professor Frank Chinegwundoh, discusses the problem of inadequate samples and describes a collection system that can help. Visit the Jan-Feb issue of Trends in Urology & Men’s Health.

Forte Medical case study within Imperial College Innovation paper

Imperial Business School: a MedTech to Market Journey

Antibiotics, better tests, UTI: Guardian publishes Forte response

A Year In Review – 2018

Mr Ased Ali – Making Urine Samples Trustworthy

Knowledge of Men’s Health Dangerously Low

Peezy Midstream Case Study at NHS NIHR Conference 2018

Forte Medical: Series A investment growth round is open

Disruptive TV: Giant Live Health Innovators

Trends in Urology & Men’s Health: solving the problem of contaminated urine samples

WEB MAP

GET IN TOUCH

Forte Medical

SOCIAL MEDIA

Latest from Twitter